AU2002216314A1 - Heterocyclic angiogenesis inhibitors - Google Patents
Heterocyclic angiogenesis inhibitorsInfo
- Publication number
- AU2002216314A1 AU2002216314A1 AU2002216314A AU1631402A AU2002216314A1 AU 2002216314 A1 AU2002216314 A1 AU 2002216314A1 AU 2002216314 A AU2002216314 A AU 2002216314A AU 1631402 A AU1631402 A AU 1631402A AU 2002216314 A1 AU2002216314 A1 AU 2002216314A1
- Authority
- AU
- Australia
- Prior art keywords
- angiogenesis inhibitors
- heterocyclic
- heterocyclic angiogenesis
- inhibitors
- angiogenesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23927600P | 2000-10-12 | 2000-10-12 | |
US60/239,276 | 2000-10-12 | ||
PCT/IB2001/002722 WO2002030886A2 (en) | 2000-10-12 | 2001-10-12 | Heterocyclic angiogenesis inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002216314A1 true AU2002216314A1 (en) | 2002-04-22 |
Family
ID=22901433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002216314A Abandoned AU2002216314A1 (en) | 2000-10-12 | 2001-10-12 | Heterocyclic angiogenesis inhibitors |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020128232A1 (en) |
AU (1) | AU2002216314A1 (en) |
WO (1) | WO2002030886A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003223930A1 (en) * | 2002-06-14 | 2003-12-31 | Novo Nordisk A/S | Pharmaceutical use of boronic acids and esters thereof |
MXPA06002017A (en) | 2003-08-21 | 2006-05-31 | Osi Pharm Inc | N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors. |
US7521448B2 (en) * | 2003-08-21 | 2009-04-21 | Osi Pharmaceuticals, Inc. | N-substituted benzimidazolyl c-Kit inhibitors |
US7442709B2 (en) | 2003-08-21 | 2008-10-28 | Osi Pharmaceuticals, Inc. | N3-substituted imidazopyridine c-Kit inhibitors |
EP1758891A2 (en) * | 2004-06-15 | 2007-03-07 | Pfizer Japan Inc. | Benzimidazolone carboxylic acid derivatives |
US7737163B2 (en) * | 2004-06-15 | 2010-06-15 | Pfizer Inc. | Benzimidazolone carboxylic acid derivatives |
KR20070086865A (en) * | 2004-12-01 | 2007-08-27 | 오에스아이 파마슈티컬스, 인코포레이티드 | N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
JP4130220B1 (en) | 2005-02-22 | 2008-08-06 | ファイザー株式会社 | Oxindole derivatives as 5HT4 receptor agonists |
DE102006014685A1 (en) * | 2006-03-28 | 2007-10-04 | Sanofi-Aventis | New bicyclic imidazolone derivatives useful as endothelial lipase inhibitors, e.g. for treating disorders of fat metabolism or glucose utilization |
CN105399731A (en) * | 2008-12-24 | 2016-03-16 | 比亚尔-珀特拉和Ca股份公司 | Pharmaceutical Compounds |
US8735406B2 (en) * | 2009-09-09 | 2014-05-27 | Dainippon Sumitomo Pharma Co., Ltd. | 8-oxodihydropurine derivative |
AU2018374469B2 (en) | 2017-11-29 | 2022-06-16 | F. Hoffmann-La Roche Ag | Target interference suppressed anti-drug antibody assay |
CN107915721A (en) * | 2017-12-22 | 2018-04-17 | 田立志 | A kind of sulfamide derivative and its application as Nampt inhibitor in antitumor drug |
CN108042539A (en) * | 2017-12-22 | 2018-05-18 | 田立志 | A kind of sulfamide derivative, preparation method and its application in antitumor drug |
CN108042538A (en) * | 2017-12-22 | 2018-05-18 | 田立志 | A kind of sulfamide derivative and its application as NAMPT inhibitor |
CN107903246A (en) * | 2017-12-22 | 2018-04-13 | 田立志 | A kind of sulfamide derivative, preparation method and its it is antitumor in application |
CN107954987A (en) * | 2017-12-22 | 2018-04-24 | 田立志 | A kind of sulfamide derivative and its application in antitumor drug |
CN107987060A (en) * | 2017-12-22 | 2018-05-04 | 田立志 | A kind of sulfamide derivative and its application as NAMPT inhibitor in antitumor drug |
CN107954988A (en) * | 2017-12-22 | 2018-04-24 | 田立志 | A kind of sulfamide derivative, preparation method and its application as NAMPT inhibitor in antitumor drug |
AU2021294222A1 (en) | 2020-06-16 | 2023-01-19 | F. Hoffmann-La Roche Ag | Method for determining the free antigen of an antibody in a sample |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3926982A (en) * | 1974-07-03 | 1975-12-16 | Squibb & Sons Inc | Substituted benzimidazolinethiones |
DD204258A1 (en) * | 1981-12-28 | 1983-11-23 | Adw Ddr | PROCESS FOR THE PREPARATION OF BENZIMIDAZOLO / 1,2-D / (1,2,4) THIADIAZOLINENE |
DD204259A1 (en) * | 1981-12-28 | 1983-11-23 | Adw Ddr | PROCESS FOR THE PREPARATION OF BENZIMIDAZOLO / 2,1-B / (1,3,5) THIADIAZINES |
AU5982298A (en) * | 1997-03-07 | 1998-09-29 | A/S Gea Farmaceutisk Fabrik | Process for the preparation of 2-{{(2-pyridinyl)me thyl}sulfinyl}-1h-benzimidazoles and novel compounds of use for such purpos |
AU1734401A (en) * | 1999-12-09 | 2001-06-18 | Mitsubishi Pharma Corporation | Carboxyamido derivatives |
US6506738B1 (en) * | 2000-09-27 | 2003-01-14 | Bristol-Myers Squibb Company | Benzimidazolone antiviral agents |
-
2001
- 2001-10-12 US US09/975,315 patent/US20020128232A1/en not_active Abandoned
- 2001-10-12 WO PCT/IB2001/002722 patent/WO2002030886A2/en active Application Filing
- 2001-10-12 AU AU2002216314A patent/AU2002216314A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20020128232A1 (en) | 2002-09-12 |
WO2002030886A2 (en) | 2002-04-18 |
WO2002030886A3 (en) | 2003-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6623201A (en) | Colchinol derivatives as angiogenesis inhibitors | |
IL153484A0 (en) | Colchinol derivatives as angiogenesis inhibitors | |
AU2001258771A1 (en) | -secretase inhibitors | |
AU2001237041A1 (en) | Kinase inhibitors | |
SI1686119T1 (en) | Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors | |
AU4882101A (en) | Mmp-12 inhibitors | |
AU2001244399A1 (en) | Gamma-secretase inhibitors | |
AU2002250394A1 (en) | Rho-kinase inhibitors | |
AU2002245709A1 (en) | Rho-kinase inhibitors | |
AU2001296961A1 (en) | 17-beta-hydroxysteroid dehydrogenase-ii inhibitors | |
AU2002216314A1 (en) | Heterocyclic angiogenesis inhibitors | |
AU2001230537A1 (en) | Pyridoxazine derivatives | |
AU2001285750A1 (en) | Urokinase inhibitors | |
AU2002213978A1 (en) | Substituted C-cyclohexylmethylamine derivatives | |
AU2002222627A1 (en) | Tak1 inhibitors | |
AU2002232468A1 (en) | Pharmaceutical heterocyclic compounds | |
AU2001258841A1 (en) | Heterocyclic compounds | |
AU2001289937A1 (en) | Substituted 1-aminobutan-3-ol derivatives | |
AU2002349621A1 (en) | Angiogenesis inhibitor | |
AU3235100A (en) | Prothease inhibitors | |
AU2001230565A1 (en) | Perfluoroisopropylbenzene derivatives | |
AU1588901A (en) | Protease inhibitors | |
AU1474801A (en) | Protease inhibitors | |
AU2001255408A1 (en) | Tetrahydro-azepinone derivatives as thrombin inhibitors | |
AU2001276354A1 (en) | Hetaryl-substituted heterocycles |